16.8: Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called smart or intelligent drug delivery systems.

Based on how the stimulus is applied, these systems are classified into open-loop and closed-loop systems. Open-loop systems are externally regulated and rely on physical triggers such as temperature, ultrasound, magnetic fields, or electric current. They do not self-monitor physiological conditions and require an external energy source to initiate drug release. Examples include thermally activated systems that utilize polymers with temperature-sensitive swelling behavior and iontophoresis-based systems that use electric current to drive charged drugs across membranes. Osmotic and hydrodynamic systems operate through pressure buildup generated by water influx or swelling agents, pushing the drug through an orifice at a controlled rate. Photo-activated systems involve reversible changes in polymer structure upon exposure to light, while ultrasound-activated systems use ultrasonic energy to disrupt the matrix and release drugs. Vapor pressure-based devices contain liquefied gases that vaporize at body temperature, generating pressure to expel the drug. Mechanical systems involve manual activation, such as metered-dose sprays.

Closed-loop or self-regulated systems respond to internal physiological changes without external intervention. These include chemical triggers like pH shifts, ion concentration, hydrolysis, and biological cues such as enzyme activity or inflammation. pH-sensitive systems exploit the pH gradient in the gastrointestinal tract or within specific tissues to control drug solubility, degradation, or swelling. Ion-activated systems rely on ion-exchange reactions to dissociate drug-resin complexes. Hydrolysis-activated systems involve polymer degradation through water interaction, common in microsphere-based injectables using biodegradable polymers. Chelation-activated systems release drugs in response to metal-ion-induced hydrolysis.

Biological stimuli include enzyme-activated systems in which drug release is mediated by the enzymatic breakdown of polymers or by enzymatically induced pH changes. Urea-responsive and glucose-responsive systems use urease and glucose oxidase, respectively, to alter local pH and trigger drug release. Inflammation-activated systems rely on oxidative species at inflamed sites to degrade drug carriers. In contrast, antibody-interaction systems control release through antigen-antibody binding, often used in targeting systems for drug antagonists like naltrexone. These approaches enhance specificity, reduce systemic side effects, and improve therapeutic efficiency.

Stimuli-activated DDS release drugs in response to specific triggers.

Many use hydrogels—3D hydrophilic polymer networks—that swell or shrink to regulate release, making them smart systems.

These operate as either open-loop or closed-loop mechanisms.

Open-loop systems rely on externally applied stimuli to initiate or inhibit drug release.

Stimuli include temperature changes, ultrasound, magnetic fields, or electric currents.

But closed-loop systems are self-regulated. They detect internal physiological changes—such as shifts in pH, enzyme activity, or metabolic signals—and adjust drug release accordingly.

These systems can also be classified based on the stimulus type.

Physical triggers include osmotic, hydrodynamic, or vapor pressure; mechanical force, magnetic fields, temperature, light, ultrasound, and electrical current.

Chemical triggers involve pH variations, ion exchange, hydrolysis, or chelation.

Biological triggers include enzyme activity, inflammation, or antibody interactions.

These approaches enable precise and responsive drug delivery.